Pharmacokinetics and Pharmacodynamics of Biphasic Insulin Aspart 30 and Biphasic Human Insulin 30 in Type 2 Diabetes
Clinical trial NCT00825253 · COMPLETED
Trial details
- NCT number
- NCT00825253
- Sponsor
- Novo Nordisk A/S
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2007-03-01
- Primary completion
- 2007-05-01
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.